Registry of patients with coronary artery issues and platelet test results
Online Assistance for Stent Thrombosis
This study collects information from patients with coronary artery disease to see how well their blood-thinning medications work and to find the best treatment options for them.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 5000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Action, France Academic / other |
| Locations | 1 site (Paris) |
| Trial ID | NCT02762162 on ClinicalTrials.gov |
What this trial studies
The Onassist Project is a registry that collects data from patients with coronary artery disease who have undergone functional testing to measure the effectiveness of antiplatelet medications and/or have had their genetic response to these drugs assessed. This project aims to evaluate individual risks of stent thrombosis by combining functional and pharmacogenomic approaches. By identifying adverse drug interactions and treatment compliance issues, the registry provides tailored therapeutic recommendations to optimize drug choice and dosage. Regular follow-ups are conducted to monitor for major adverse cardiac events or bleeding complications.
Who should consider this trial
Good fit: Ideal candidates for this registry are patients with coronary artery disease who have undergone antiplatelet testing as part of their usual care.
Not a fit: Patients who refuse to participate in the registry will not benefit from the tailored therapeutic insights provided.
Why it matters
Potential benefit: If successful, this approach could lead to more personalized and effective treatment strategies for patients at risk of stent thrombosis.
How similar studies have performed: While this approach is innovative, similar studies focusing on personalized medicine in cardiology have shown promising results.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * coronary disease * antiplatelets testing performed as part of usual care and / or gentic profile of antiplatelet response done Exclusion Criteria: * patient refusing to be part of the registry
Where this trial is running
Paris
- Hopital Pitie Salpetriere — Paris, France (Recruiting)
Study contacts
- Study coordinator: Jean Philippe COLLET, MD, PhD
- Email: jean-philippe.collet@aphp.fr
- Phone: +33142162962
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.